Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Effectiveness of Imiquimod Creams for External Genital Warts
NCT00735462Phase 3Completed
- Sponsor
- Graceway Pharmaceuticals
- Start
- Aug 2008
- Primary completion
- Jul 2009
- Modality
- Nucleic Acid-Directed Small Molecules, Irreversible Covalent Inhibitors, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of imiquimod in condyloma acuminatum, sponsored by Graceway Pharmaceuticals. Started Aug 2008; status: completed.
02
Drugs
imiquimod
03
Conditions
condyloma acuminatum
Beyond the preview
Go deeper on NCT00735462.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00735462.